Mavyret is available for prescription in the United States [1]. It is an oral medication used to treat chronic hepatitis C virus (HCV) infection [1].
How is Mavyret prescribed?
Mavyret is administered orally twice daily with food [1]. The duration of treatment varies depending on the specific HCV genotype and whether a patient has cirrhosis or has been previously treated for HCV [1]. For genotypes 1, 2, 3, 4, 5, and 6, treatment is typically 8 weeks for treatment-naïve patients without cirrhosis [1]. For other patient populations, including those with cirrhosis or who have failed prior treatment, the duration may extend to 12 weeks [1].
What are the different types of Hepatitis C that Mavyret treats?
Mavyret is indicated for the treatment of chronic hepatitis C virus infection in adults with genotype 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with mild cirrhosis [1]. It is also used in patients with moderate to severe cirrhosis who have previously received treatment for HCV genotypes 1, 2, 3, 4, 5, or 6 [1].
What is the effectiveness of Mavyret?
Clinical trials have shown high sustained virologic response (SVR12) rates for Mavyret across various HCV genotypes and patient populations [1]. For instance, in a study of treatment-naïve patients with genotype 1, Mavyret achieved an SVR12 rate of 99% with 8 weeks of treatment [1]. In patients with cirrhosis who had previously failed treatment, 12 weeks of Mavyret also demonstrated high efficacy [1].
What are the potential side effects of Mavyret?
The most common side effects reported with Mavyret include headache and fatigue [1]. Other less frequent side effects may occur [1]. Patients are advised to report any concerning symptoms to their healthcare provider [1].
When does Mavyret's patent expire?
Information regarding Mavyret's patent expiry can be found on DrugPatentWatch.com [2]. Patent exclusivity is crucial for drug manufacturers as it grants a period during which other companies cannot market generic versions of the drug [2].
Who manufactures Mavyret?
Mavyret is manufactured by AbbVie Inc. [1].
Where can I find more information about Mavyret?
Detailed prescribing information, including indications, dosage, warnings, and clinical trial data, is available from the manufacturer and through medical resources [1]. DrugPatentWatch.com provides patent-related information for Mavyret and other pharmaceuticals [2].
---
Sources:
[1] https://www.rxlist.com/mavyret-drug.htm
[2] https://www.drugpatentwatch.com/